Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue
Provided By GlobeNewswire
Last update: Jan 13, 2025
Preliminary, unaudited revenue for the full year 2024 of approximately $174 million
Presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16th, 2024, at 9:45 a.m. PT.
Read more at globenewswire.comNASDAQ:LAB (11/13/2025, 10:38:45 AM)
1.19
+0.01 (+0.85%)
Find more stocks in the Stock Screener
